HomepageEarnings Events Newsdesk 8 hours ago Polaris Inc (PII) Polaris Announces Spring 2026 TRAILS GRANTS as Program Marks 20 Years Polaris Inc (NYSE: PII) FY 2026 Other Release Regeneron Pharmaceuticals Inc (REGN) Otarmeni™ (lunsotogene parvec-cwha) Approved by FDA as First and Only Gene Therapy for Genetic Hearing Loss; Regeneron to Provide Otarmeni for Free in the U.S. » « Exelon Corporation (EXC) ComEd Customers Save $13 Billion in Energy Costs Through Award-Winning Energy Efficiency Program Newsdesk:
